Decreasing incidence of pharmacologically and non-pharmacologically treated type 2 diabetes in Norway: a nationwide study

Ruiz, Paz Lopez‐Doriga; Stene, Lars C.; Bakken, Inger Johanne; Håberg, Siri E.; Birkeland, Kåre I.; Gulseth, Hanne Løvdal

doi:10.1007/s00125-018-4681-4

Cited by 48 publications

(56 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…A more recent study linked data from national registries with prospective data on diabetes diagnoses and antihyperglycaemic medication prescribed for all residents in Norway (aged 30-89 years) during 2009-2014. During the investigation period in that study, the prevalence of T2DM increased from 4.9% to 6.1% [55].…”

Section: The T2dm Situation In Norwaymentioning

confidence: 75%

Living with Diabetes: Personal Interviews with Pakistani Women in Norway

Abuelmagd

Håkonsen

Mahmood

et al. 2017

J Immigrant Minority Health

View full text Add to dashboard Cite

The prevalence of Type 2 diabetes (T2D) among Pakistani women in Norway is remarkably high. This study aims to assess how they live with the disease and their response to lifestyle and medical information. 120 Pakistani women living in Norway (mean age: 55.7 years) were personally interviewed about their T2D using a structured questionnaire (response rate: 95%). The participants were first-generation immigrants (mean residence time: 28.7 years) of whom 27% were illiterates. Poor health was reported by one-third, and 71% had developed macrovascular comorbidities. A majority reported physical inactivity and an unhealthy diet included religious fasting. One-third was not able to self-measure their blood glucose. There was a great variation in antidiabetic drug regimens and one-fourth had to use insulin in addition to tablets. Pakistani women in Norway showed suboptimal control of their T2D in terms of lifestyle habits, comorbidities and drug use. Low literacy and cultural factors seem to challenge adherence to lifestyle and medical information.

show abstract

Section: The T2dm Situation In Norwaymentioning

confidence: 75%

Living with Diabetes: Personal Interviews with Pakistani Women in Norway

Abuelmagd

Håkonsen

Mahmood

et al. 2017

J Immigrant Minority Health

View full text Add to dashboard Cite

show abstract

“…Further, the observed reduction in HF incidence rates is attributed to reductions in systolic and diastolic blood pressure and prevalence of hyperlipidaemia . A recent publication reported a decline in the incidence of type 2 DM in Norway . On the other hand, increases in the prevalence of AF, valvular heart disease, overweight and obesity have a negative impact on incident HF hospitalization rates.…”

Section: Discussionmentioning

confidence: 99%

“…29,30 A recent publication reported a decline in the incidence of type 2 DM in Norway. 31 On the other hand, increases in the prevalence of AF, valvular heart disease, 32 overweight 30 and obesity 33 have a negative impact on incident HF hospitalization rates. Readmission rates are influenced by burden of medical conditions, quality of treatment (of both HF symptoms and the underlying condition) as well as secondary prevention measures.…”

Section: Factors Associated With the Observed Trendsmentioning

confidence: 99%

Heart failure in Norway, 2000–2014: analysing incident, total and readmission rates using data from the Cardiovascular Disease in Norway (CVDNOR) Project

Sulo

Igland

Øverland

et al. 2019

European J of Heart Fail

View full text Add to dashboard Cite

Aims To examine trends in heart failure (HF) hospitalization rates and risk of readmissions following an incident HF hospitalization. Methods and results During 2000–2014, we identified in the Cardiovascular Disease in Norway Project 142 109 hospitalizations with HF as primary diagnosis. Trends of incident and total (incident and recurrent) HF hospitalization rates were analysed using negative binomial regression models. Changes over time in 30‐day and 3‐year risk of HF recurrences or cardiovascular disease (CVD)‐related readmissions were analysed using Fine and Grey competing risk regression, with death as competing events. Age‐standardized rates declined on average 1.9% per year in men and 1.8% per year in women for incident HF hospitalizations (both Ptrend < 0.001) but did not change significantly in either men or women for total HF hospitalizations. In men surviving the incident HF hospitalization, 30‐day and 3‐year risk of a HF recurrent event increased 1.7% and 1.2% per year, respectively. Similarly, 30‐day and 3‐year risk of a CVD‐related hospitalization increased 1.5% and 1.0% per year, respectively (all Ptrend < 0.001). No statistically significant changes in the risk of HF recurrences or CVD‐related readmissions were observed among women. In‐hospital mortality for a first and recurrent HF episode declined over time in both men and women. Conclusions Incident HF hospitalization rates declined in Norway during 2000–2014. An increase in the risk of recurrences in the context of reduced in‐hospital mortality following an incident and recurrent HF hospitalization led to flat trends of total HF hospitalization rates.

show abstract

“…Six studies that reported prevalence trends of DM among countries from Western Europe were selected [4][5][6][7][8][9]. All six studies were representative of the national populations, and the data were either population or registry based.…”

Section: Western Europementioning

confidence: 99%

“…Six studies reported data on DM incidence trends in Western Europe [5][6][7][37][38][39]. Recent DM incidence trends were quite similar among all countries, with stable trends over the last 10 years.…”

Section: Western Europementioning

confidence: 99%

Global burden of diabetes: regional disparities in prevalence, incidence, and mortality

Bota¹,

Koechlin²,

Pizot³

et al. 2019

jhi

View full text Add to dashboard Cite

Objectives: To study the trends in diabetes prevalence, incidence, and mortality over time and by region of the world. Material and methods: An online literature search was carried out in PubMed for studies reporting data on the time trends of the prevalence and of the incidence of diabetes. Studies reporting the most recent trends were selected to represent each region of the world and with the aim to cover a time span as long as possible. For mortality trends, diabetes deaths registered in the World Health Organisation (WHO) mortality database by November 2018 were extracted by gender and five-year age group for a selection of countries and for the longest period available (from 1950 to 2015). Results: Thirty-two and 11 articles were included in the analysis of trends of diabetes prevalence and incidence, respectively. The prevalence and incidence of diabetes are increasing globally. A study of the trends on a finer geographic scale revealed contrasting results and confirmed a lack of trend data, notably in Eastern Europe and other low-and middle-income regions. Mortality is increasing in South and Central America and Africa, but is stabilising in the other regions of the world. Conclusions: Trends in diabetes prevalence and incidence showed disparities among different groups of populations, which could be explained by disparities in lifestyle and access to medical facilities or could be related to the obesity epidemic. This study revealed important data gaps that have to be bridged to obtain a more complete and more accurate picture of the worldwide diabetes epidemic.

show abstract

Decreasing incidence of pharmacologically and non-pharmacologically treated type 2 diabetes in Norway: a nationwide study

Cited by 48 publications

References 25 publications

Living with Diabetes: Personal Interviews with Pakistani Women in Norway

Living with Diabetes: Personal Interviews with Pakistani Women in Norway

Heart failure in Norway, 2000–2014: analysing incident, total and readmission rates using data from the Cardiovascular Disease in Norway (CVDNOR) Project

Global burden of diabetes: regional disparities in prevalence, incidence, and mortality

Contact Info

Product

Resources

About